| Glucocorticoid-induced osteoporosis            Glucocorticoid drugs are widely used in the treatment
            of rheumatoid arthritis, polymyalgia rheumatica, asthma, inflammatory
            bowel disease,
              skin diseases, connective tissue disorders and organ transplantation.
              These drugs affect the normal remodelling process
              in bones leading to a form of osteoporosis and increased risk of
              fractures. At any
              one time, glucocorticoid are in use by approximately
              1% of the adult population although this figure increases to 2.5%
              in individuals aged 70-79. Accordingly it has been estimated that
              350,000 individuals in the UK are at risk of fractures due to glucocorticoid
            use. Recent evidence suggests that the risk of osteoporosis rises within
            3 months of the initiation of therapy. Doses of only 5mg per day
            are
            associated
            with excess risk of vertebral fractures. It is now thought that even
            the use of inhaled glucocorticoids may have an effect.               What should I do if I think I am at risk?               Talk to your doctor about your worries. The Bone Research
            Society has collaborated with the Royal College of Physicians and
            the
                National Osteporosis Society to produce detailed guidelines
                for patients              and also guidelines
                for doctors. What are the symptoms?               The symptoms are the same as listed under osteoporosis.               How is it treated?               The most effective way of preventing or reversing glucocorticoid
                  induced bone loss is with anti-resorptive drugs, specifically
                the bisphosphonates. Etidronate was the first to show an effect,
                but
                  the evidence of efficacy with alendronate and risedronate,
                the latter in both prevention and treatment mode, is better.
                Both
                    alendronate
                  after two years and risedronate after 1 year, have shown an
                effect on prevention of vertebral fractures even after they are
                discontinued.
                  Recent evidence has suggested that another drug, ibandronate,
                is also useful for reversing bone loss in patients receiving
                glucocorticoids.  Increasing the amount of calcium and Vitamin D in the diet is also
            important and weight-bearing exercise is recommended.               Questions patients ask What are the most likely signs of glucocorticoid-induced
            osteoporosis?The most likely indication is that a minor slip or fall unexpectedly
            causes a fracture.
 More information BRS, NOS and The
              Royal Society of PhysiciansGuidelines for Patients
 Guidelines for health professionals
 National Osteoporosis Society
 National Institute for Clinical Excellence
 back to list        |